Cancer pharmacogenomics and pharmacoepidemiology: setting a research agenda to accelerate translation (Q34315833)

1 August 2017

title

Cancer pharmacogenomics and pharmacoepidemiology: setting a research agenda to accelerate translation (English)

1 reference

1 August 2017

0 references

1 reference

1 reference

Rachel Ballard-Barbash

object named as

Rachel Ballard-Barbash

26

1 reference

1 August 2017

8

Richard M Weinshilboum

1 reference

1 August 2017

Geoffrey Liu

14

0 references

Muin J. Khoury

6

object named as

Muin J Khoury

1 reference

1 August 2017

21

Christine B Ambrosone

1 reference

1 August 2017

15

David A Flockhart

1 reference

1 August 2017

9

Mark J Ratain

1 reference

1 August 2017

22

Mary V Relling

1 reference

1 August 2017

Andrew N Freedman

1

1 reference

1 August 2017

Leah B Sansbury

2

1 reference

1 August 2017

William D Figg

3

1 reference

1 August 2017

Arnold L Potosky

4

1 reference

1 August 2017

Sheila R Weiss Smith

5

1 reference

1 August 2017

Stefanie A Nelson

7

1 reference

1 August 2017

Howard L McLeod

10

1 reference

1 August 2017

Robert S Epstein

11

1 reference

1 August 2017

Geoffrey S Ginsburg

12

1 reference

1 August 2017

Richard L Schilsky

13

1 reference

1 August 2017

Cornelia M Ulrich

16

1 reference

1 August 2017

Robert L Davis

17

1 reference

1 August 2017

Lawrence J Lesko

18

1 reference

1 August 2017

Issam Zineh

19

1 reference

1 August 2017

Gurvaneet Randhawa

20

1 reference

1 August 2017

Nat Rothman

23

1 reference

1 August 2017

Heng Xie

24

1 reference

1 August 2017

Margaret R Spitz

25

1 reference

1 August 2017

James H Doroshow

27

1 reference

1 August 2017

Lori M Minasian

28

1 reference

1 August 2017

language of work or name

English

0 references

publication date

13 October 2010

1 reference

Journal of the National Cancer Institute

1 August 2017

published in

1 reference

1 August 2017

volume

102

1 reference

1 August 2017

issue

22

1 reference

1 August 2017

page(s)

1698-1705

1 reference

Genome-wide associations and functional genomic studies of musculoskeletal adverse events in women receiving aromatase inhibitors

1 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2982809

Somatic EGFR mutation and gene copy gain as predictive biomarkers for response to tyrosine kinase inhibitors in non-small cell lung cancer

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2982809

Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2982809

Association between CYP2D6 polymorphisms and outcomes among women with early stage breast cancer treated with tamoxifen

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2982809

Aspirin use and survival after diagnosis of colorectal cancer

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2982809

CYP2D6 and tamoxifen: DNA matters in breast cancer

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2982809

KRAS mutation testing in colorectal cancer

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2982809

The genomic applications in practice and prevention network

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2982809

American Society of Clinical Oncology provisional clinical opinion: testing for KRAS gene mutations in patients with metastatic colorectal carcinoma to predict response to anti-epidermal growth factor receptor monoclonal antibody therapy

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2982809

Recommendations from the EGAPP Working Group: can UGT1A1 genotyping reduce morbidity and mortality in patients with metastatic colorectal cancer treated with irinotecan?

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2982809

Breast cancer treatment outcome with adjuvant tamoxifen relative to patient CYP2D6 and CYP2C19 genotypes

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2982809

The impact of cytochrome P450 2D6 metabolism in women receiving adjuvant tamoxifen

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2982809

Pharmacogenetics of tamoxifen biotransformation is associated with clinical outcomes of efficacy and hot flashes

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2982809

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2982809

Mercaptopurine therapy intolerance and heterozygosity at the thiopurine S-methyltransferase gene locus

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2982809

Association between CYP2D6 *10 genotype and survival of breast cancer patients receiving tamoxifen treatment.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2982809

Impact of CYP2D6*10 on recurrence-free survival in breast cancer patients receiving adjuvant tamoxifen therapy

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2982809

Clinical implications of CYP2D6 genotypes predictive of tamoxifen pharmacokinetics in metastatic breast cancer

28 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20944079

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1093/JNCI/DJQ390

1 reference

1 August 2017

1 reference

1 August 2017

1 reference